AVEO Oncology's (AVEO) Tivozanib Receives Disappointing News from FDA Oncologic Drugs Advisory Committee
Tweet Send to a Friend
AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. today reported that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE